Adamas Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAdamas Pharmaceuticals

Adamas Pharmaceuticals(ADMS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

pneumococcal pneumonia

,

haemophilus influenzae

,

streptococcus pneumoniae

,

,

chronic obstructive pulmonary disease

,

respiration disorders

,

,

,

rotavirus infections

,

haemophilus infections

,

neisseria meningitidis

,

respiratory syncytial virus infections

,

influenza in birds

,

,

,

,

meningococcal infections

,

respiratory tract diseases

,

,

,

pneumococcal infections

,

orthomyxoviridae infections

,

gram-negative bacterial infections

,

,

,

,

,

,

human influenza

,

haemophilus influenzae type b

,

,

h1n1 subtype influenza a virus

,

,

healthy volunteers/patients

,

,

,

respiratory tract infections

,

communicable diseases

,

disease progression

,

,

,

,

bronchial spasm

,

multiple sclerosis

,

,

,

,

,

infectious encephalitis

,

immunologic tests

,

,

,

,

,

drug-related side effects and adverse reactions

,

vaccine-preventable diseases

,

pneumococcal pneumonia

,

haemophilus influenzae

,

streptococcus pneumoniae

,

,

chronic obstructive pulmonary disease

,

respiration disorders

,

,

,

rotavirus infections

,

haemophilus infections

,

neisseria meningitidis

,

respiratory syncytial virus infections

,

influenza in birds

,

,

,

,

meningococcal infections

,

respiratory tract diseases

,

,

,

pneumococcal infections

,

orthomyxoviridae infections

,

gram-negative bacterial infections

,

,

,

,

,

,

human influenza

,

haemophilus influenzae type b

,

,

h1n1 subtype influenza a virus

,

,

healthy volunteers/patients

,

,

,

respiratory tract infections

,

communicable diseases

,

disease progression

,

,

,

,

bronchial spasm

,

multiple sclerosis

,

,

,

,

,

infectious encephalitis

,

immunologic tests

,

,

,

,

,

drug-related side effects and adverse reactions

,

vaccine-preventable diseases

paramyxoviridae infections

,

influenza in birds

,

,

multiple sclerosis

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

,

,

,

,

haemophilus infections

,

haemophilus influenzae type b

,

meningococcal infections

,

flavivirus infections

,

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use